Lactulose Fresenius

Lactulose, the active ingredient in Lactulose Fresenius, is an osmotic laxative presented as an oral solution for oral use. The sugar‑derived disaccharide is not absorbed systemically, allowing it to act locally within the gastrointestinal tract. It is employed to relieve constipation and to lower blood ammonia levels in patients with hepatic encephalopathy.

GNH USA supplies Lactulose Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

Lactulose is an osmotic laxative used in gastrointestinal and hepatic conditions. - Constipation: softens stools and promotes regular bowel movements by increasing intestinal water content. - Hepatic encephalopathy: lowers blood ammonia levels, helping improve mental status in patients with liver disease. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia concentrations to reduce the risk of episodic neurological deterioration.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Abdominal cramping or discomfort. - Flatulence and bloating. - Diarrhea or loose stools. - Nausea or mild vomiting. - Increased thirst. - Transient electrolyte shifts (e.g., mild hyponatremia).

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance requiring medical attention. - Acute abdominal pain with signs of intestinal obstruction. - Allergic reactions such as rash, itching, or swelling. - Hypernatremia in susceptible individuals. - Rare cases of rectal bleeding.

When prescribing lactulose, clinicians should consider several safety aspects to minimize risks. - Renal function: assess renal status before initiating therapy, as reduced clearance may increase osmotic load. - Electrolyte balance: monitor serum electrolytes, especially potassium and sodium, during prolonged use. - Diabetes mellitus: use caution in patients with diabetes because lactulose can affect blood glucose monitoring. - Concomitant laxatives: avoid combining with other strong laxatives to prevent excessive fluid loss. - Hepatic impairment: dose may need adjustment in severe liver disease. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lactulose can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide): may counteract lactulose’s laxative effect. - High‑dose mineral supplements (magnesium, calcium): can increase osmotic burden and risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate electrolyte loss; monitor serum levels. - Antibiotics that alter gut flora: may affect lactulose metabolism and efficacy. - Antacids: may change taste but have minimal clinical impact.